Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
€ 591.77 0.42%

Geschäftsbericht 2024
hinzugefügt 05.02.2025

report update icon

Regeneron Pharmaceuticals Kennzahlen 2011-2025 | REGN

Kennzahlen Jährlich Regeneron Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

17.6 25.3 19.3 8.3 14.8 17.4 18.5 33.7 40.3 68.1 120.4 67.6 22.1 -36.3

P/S

5.5 7.6 6.9 4.2 6.1 4.7 6.8 6.9 7.4 10.6 14.9 13.6 12.0 18.1

EPS

40.9 37.0 40.5 76.4 32.6 19.4 22.6 11.3 8.6 6.2 3.4 4.2 7.9 -2.5

EV (Enterprise Value)

83.6 B 105 B 87.1 B 70.5 B 55.9 B 38.8 B 46.8 B 42.2 B 38.1 B 44.4 B 42.6 B 29.2 B 17.2 B 8.41 B

EBITDA per Share

41.5 41.9 47.4 87.3 35.4 22.2 24.9 20.9 13.7 12.9 8.86 8.18 5.22 -1.92

EV/EBITDA

7.6 13.9 14.5 16.3 17.8 24.8 32.0 46.5 35.5 33.6 -45.1

PEG

0.6 0.92 0.57 0.15 0.58 -1.2 0.18 1.06 1.04 0.87 -5.99 -1.49 0.05 0.38

P/B

2.6 3.9 3.7 3.6 4.7 3.3 5.2 6.6 8.1 11.8 16.5 14.7 13.3 16.6

P/CF

17.6 21.8 16.7 9.4 19.9 18.4 25.0 39.0 37.5 66.3 102.2 67.1 -133.5 -40.5

ROE %

15.03 15.22 19.14 43.03 31.86 19.08 27.91 19.51 20.13 17.40 13.69 21.74 60.24 -45.65

ROA %

11.69 11.95 14.85 31.75 20.47 14.29 20.83 13.67 12.84 11.34 8.99 14.38 36.06 -16.75

ROCE %

13.60 15.58 20.91 47.67 32.44 17.39 24.63 27.26 23.22 26.09 26.06 28.66 23.88 -17.46

Current Ratio

4.5 4.7 4.5 3.8 2.8 3.7 4.5 3.8 2.6 3.6 3.3 6.0 7.4 4.4

DSO

152.7 153.0 170.4 103.9 111.9 124.0 122.0 122.7 121.0 130.6 131.7 154.7 183.5 84.4

DIO

- - - - - 660.5 968.0 667.5 486.4 221.7 229.4 165.3 123.8 1173.6

DPO

- - - - - 195.1 183.5 163.8 164.4 131.0 177.2 145.5 168.3 2401.2

Betriebszyklus

152.7 153.0 170.4 103.9 111.9 784.6 1090.0 790.2 607.4 352.3 361.1 319.9 307.3 1258.0

Finanzkreislauf

152.7 153.0 170.4 103.9 111.9 589.5 906.5 626.4 443.0 221.3 184.0 174.4 139.0 -1143.3

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Regeneron Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

12.4 13.25 6.7 9.48 9.05 7.64 - 12.31 7.9 9.12 - 15.37 29.51 10.58 10.9 7.98 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.5 5.12 4.44 1.62 3.64 3.66 2.36 2.41 2.53 1.88 1.74 1.49 2.04 1.89 0.74 0.89 0.89 0.89 0.89 0.98 1.44 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -0.49

EBITDA per Share

- - 8.03 - - 9.77 - 13.7 10.3 12.5 - 19.4 31.9 11.2 - 11.6 7.04 6.89 - 8.18 3.83 4.88 - 6.78 6.42 5.61 - 6.29 5.88 4.44 - 4.18 3.25 3.38 - 4.3 3.66 2.93 - 8.56 2.39 2.3 - 2.72 1.81 1.68 - 2.42 1.11 0.33 - -0.39 -0.5 -0.38

ROE %

16.37 15.83 14.23 17.70 19.79 19.87 15.14 24.60 27.92 44.29 39.25 49.68 47.86 35.51 31.86 28.58 26.98 20.59 19.08 21.31 22.06 26.61 27.91 21.37 20.90 20.91 19.50 22.37 22.00 20.10 20.13 18.68 18.48 19.40 17.40 16.70 14.47 12.68 14.11 15.51 19.21 20.16 21.71 54.21 62.35 64.04 59.91 11.47 -16.74 -35.77 -45.65 -12.84 -12.87 -8.94

ROA %

12.78 12.36 11.11 13.77 15.39 15.92 12.14 19.04 17.49 31.91 27.59 34.29 32.30 23.11 20.47 19.12 18.74 14.82 14.29 15.93 16.48 19.87 20.83 15.82 15.18 14.91 13.67 15.32 14.69 13.08 12.84 11.98 11.93 12.59 11.34 10.92 9.52 8.40 9.36 10.29 12.73 13.34 14.38 33.71 38.12 38.85 36.06 9.41 -4.50 -12.91 -16.75 -4.71 -4.72 -3.28

ROCE %

15.06 15.27 15.51 18.43 19.68 20.81 17.39 28.10 33.09 49.85 42.12 51.67 50.52 34.35 21.86 28.51 25.62 22.51 13.83 20.99 21.49 25.75 20.74 29.85 31.81 33.66 25.08 33.23 32.27 29.87 22.11 32.85 35.43 38.31 27.93 36.39 57.96 56.99 57.65 61.32 41.14 40.78 28.07 44.32 48.44 47.36 25.06 13.02 -15.26 -34.71 -32.89 -12.03 -12.42 -8.44

Current Ratio

4.6 4.6 4.7 4.4 4.6 4.6 4.5 4.4 - 4.1 3.8 3.7 3.4 3.1 2.8 2.8 2.8 2.8 4.0 4.0 4.0 4.0 3.9 3.9 3.9 3.9 3.3 3.3 3.3 3.3 2.8 2.8 2.8 2.8 2.9 2.9 2.9 2.9 3.0 3.0 3.0 2.9 3.0 3.0 3.0 3.0 2.5 2.5 2.5 2.5 1.6 1.6 1.6 1.6

DSO

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Finanzkreislauf

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Alle Zahlen in USD-Währung